Professional Documents
Culture Documents
Im Toledo Case1 Day4 111121
Im Toledo Case1 Day4 111121
– COLLEGE OF MEDICINE
Department of Internal Medicine
DAY 4 ACTIVITY
Instruc ons:
● Use Harrison’s Principles of Internal Medicine 20th edi on, Bate’s Guide to Physical Examina on and History Taking, or Clinical Prac ce Guidelines as your reference in answering this case. You may also
use the o cial textbooks used by other departments.
● Indicate the name of the book, chapter and page number in the reference column. Failure to write the reference will incur deduc on from the total grade.
Case:
Bones ● There is no abnormality of the imaged so ssues or skeleton; in par cular, there are no rib fractures.
Cardiac/Medias num/CT ● The heart is not enlarged and the cardiac and medias nal contours are normal.
ra o ● Cardiothoracic ra o is 0.45
What medicines will you give SPECIFIC FOR THIS PATIENT considering your history and physical examina on ndings, diagnos c test results, and working diagnosis?
Make a brief drug study. Answers in bullet format. Key words or points only.
Omeprazole Proton Pump Inhibitor It blocks the nal step in gastric acid secre on 20 mg BID PO for 14 days Concomitant use with nel navir. Hypomagnasaemia, nausea, vomi ng, Decrease plasma concentra ons of
by speci c inhibi on of adenosine cough nel navir and atazanavir.
triphosphatase (ATPase) enzyme system present Increased risk of
on the secretory surface of the gastric parietal Monitor: Serum Mg+ level hypomagnesaemia with diure cs. The Washington
cell. Both basal and s mulated acid are Manual of Medical
inhibited. Therapeu cs 36th
edi on (PDF
Clarithromycin Macrolide It selec vely binds to the 50S ribosomal subunit 500 mg BID PO for 14 days Hypersensi vity to clarithromycin Hepa c dysfunc on (e.g. increased May result in signi cant version) page 1873
of suscep ble bacteria and prevents the or any macrolide an bio cs. liver enzymes, hepatocellular and/or hypoglycaemia with oral
ac vated amino acids transloca on, resul ng in cholesta c hepa s with or without hypoglycaemics (e.g. sulfonylureas, Good and Gilman’s
inhibi on of intracellular protein synthesis. jaundice); exacerba on or new onset of repaglinide, nateglinide) and The Pharmacological
myasthenia gravis. insulin. Basis
of Therapeu cs.
Monitor: AST, ALT Chapter 49 pages
Metronidazole Nitroimidazole It Interacts with the microbial DNA to break its 500 mg TID PO for 14 days Hypersensi vity to metronidazole Severe neurological disturbances, Confusional state or acute 916-918
an microbials strand and helical structure leading to inhibi on and other nitroimidazoles. encephalopathy, convulsive seizures, psychosis with disul ram.
of protein synthesis, degrada on, and cell asep c meningi s, peripheral and op c May poten ate an coagulant Harrison’s Principles
death. neuropathy, paraesthesia; e ect of warfarin. of Internal Medicine
superinfec on 20th edi on Chapter
93, page 686;
Monitor: CBC with di eren als Chapter 317, page
2228-2238
Misoprostol Prostaglandin E1 It protects the GI mucosa by inhibi ng basal, 200 mcg QID PO for 14 days Pregnancy Diarrhoea, dyspepsia, atulence, Mg-containing antacids may
analogue s mulated and nocturnal acid secre on and by abdominal pain, nausea, vomi ng, aggravate misoprostol-induced
reducing the volume of gastric secre ons and rashes, dizziness, headache, increased diarrhoea.
increasing bicarbonate and mucus secre on. uterine contrac lity, abnormal vaginal
It also induces contrac ons of smooth muscle bleeding.
bres of the myometrium and relaxa on of the
cervix uteri. Monitor: if female, pregnancy test rst
Ferrous sulfate Dietary supplement Ferrous sulfate facilitates oxygen transport via 65 mg TID OD Gastrointes nal irrita on, nausea, May decrease the absorp on of
Hb. It is used as iron source as it replaces iron vomi ng, epigastric pain, tetracyclines, uoroquinolones
found in Hb, myoglobin and other enzymes. diarrhoea, cons pa on, blackening Monitor: Hb and haematocrit; RBC (e.g. cipro oxacin, nor oxacin,
of stool, tooth discoloura on, count and indices, serum ferri n, o oxacin), bisphosphonates,
abdominal discomfort transferrin satura on, total iron- levodopa, methyldopa,
binding capacity, serum iron penicillamine, entacapone and
concentra on and erythrocyte levothyroxine.
protoporphyrin concentra on.
Based on the data presented (HPI, PE, Diagnos c test results), formulate
addi onal medical orders for this pa ent especially a er knowing the Ra onale Reference
endoscopy result of this pa ent and other laboratory tests.
● Monitor vital signs ● To monitor the condi on of the pa ent Philippine Society of Gastroenterology 3rd
edi on (2000). H. pylori in Pep c Ulcer Disease
page 99
● Request for CBC with di eren als, Serum Crea nine, BUN, AST, ALT ● To monitor anemia, kidney func on, liver func on, and input The Washington Manual of Medical Therapeu cs
level, and Urinalysis. and output status. 36th edi on (PDF version) pages 1820 & 1821